|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.505 RUB | +10.15% |
|
-.--% | - |
| Market Cap | 1.36B 103B 1.19B 1.1B 1.03B 1.92B 128B 1.96B 13.17B 5.1B 63.08B 5.09B 4.98B 219B | P/E 2021 |
-2.42x | P/E 2022 | -6.53x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 159B 1.84B 1.69B 1.58B 2.97B 197B 3.02B 20.32B 7.87B 97.32B 7.86B 7.68B 338B | EV / Sales 2021 |
5.43x | EV / Sales 2022 | 5.51x |
| Free-Float |
95.22% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +10.15% |
| 5 years | 2.64 |  | 7 |
| 10 years | 2.64 | | 18.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 01/01/2014 | |
Alexey Shafranov
DFI | Director of Finance/CFO | 47 | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Gorelik
BRD | Director/Board Member | 47 | 01/01/2007 |
| Director/Board Member | 46 | 01/01/2013 | |
Dmitriy Genkin
CHM | Chairman | 57 | 01/01/2005 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.15% | -.--% | -.--% | -.--% | 25.27M | |
| +0.62% | +1.64% | +40.93% | +146.61% | 996B | |
| +1.66% | +7.06% | +60.56% | +49.43% | 580B | |
| +3.65% | +12.28% | +31.12% | +80.13% | 415B | |
| +5.66% | -2.44% | +22.01% | +15.66% | 326B | |
| +1.34% | +6.74% | +32.63% | +41.70% | 280B | |
| +1.09% | +6.90% | +37.22% | +24.53% | 284B | |
| +1.32% | +12.69% | -27.48% | -41.27% | 210B | |
| +1.34% | +5.22% | +26.71% | +58.07% | 190B | |
| -0.60% | +0.16% | +17.02% | +61.91% | 155B | |
| Average | +2.62% | +3.43% | +24.07% | +43.68% | 343.68B | |
| Weighted average by Cap. | +1.76% | +2.18% | +34.24% | +70.92% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 438M 33.22B 385M 355M 332M 622M 41.36B 634M 4.26B 1.65B 20.39B 1.65B 1.61B 70.85B | 380M 28.77B 334M 307M 287M 539M 35.83B 549M 3.69B 1.43B 17.66B 1.43B 1.39B 61.37B |
| Net income | -698M -52.86B -613M -565M -528M -990M -65.82B -1.01B -6.77B -2.62B -32.45B -2.62B -2.56B -113B | -207M -15.72B -182M -168M -157M -294M -19.58B -300M -2.01B -780M -9.65B -779M -762M -33.54B |
| Net Debt | 693M 52.51B 609M 561M 524M 983M 65.38B 1B 6.73B 2.61B 32.23B 2.6B 2.55B 112B | 736M 55.79B 647M 596M 557M 1.04B 69.47B 1.06B 7.15B 2.77B 34.25B 2.76B 2.7B 119B |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LIFE Stock
Select your edition
All financial news and data tailored to specific country editions
